ReviewCancers2019

Efficacy and Adverse Events in Metastatic Melanoma Patients Treated with Combination BRAF Plus MEK Inhibitors Versus BRAF Inhibitors: A Systematic Review.

Austin Greco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.